"\u043D\u0430\u0443\u0447\u043D\u0430 \u0441\u0442\u0430\u0442\u0438\u044F"@bg . . . "Helmut Schumacher" . . . . "59" . "artikull shkencor i botuar m\u00EB 01 janar 2012"@sq . . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@sq . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 2012"@uk . . "Peggy Gao" . . "Giuseppe Mancia" . . . . "1" . "22192672" . . . "article scientifique publi\u00E9 en 2012"@fr . . "Paolo Verdecchia" . "wetenschappelijk artikel"@nl . "10.1016/J.JACC.2011.09.040" . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@sq . "2012-01-01T00:00:00Z"^^ . "Salim Yusuf" . "Bryan Williams" . . "Michael Weber" . "scientific article published on 01 January 2012"@en . "74-83" . . . "Michael B\u00F6hm" . . . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@en . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@nl . . . . . . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@en . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@nl . "Janice Pogue" . "Josep Redon" . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@nl . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@en . "Khalid Yusoff" . . "ONTARGET Investigators" . "2012 \u0569\u057E\u0561\u056F\u0561\u0576\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E"@hy . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xineru de 2012"@ast . "Robert Fagard" . . . "Peter Sleight" . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@sq . "Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)"@en . .